Ute Hofmann
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 47
- Antibiotics Pharmacokinetics and Efficacy 12
- Drug-Induced Hepatotoxicity and Protection 11
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 39
-
- Pharmacological Effects and Toxicity Studies 12
- Biochemistry top 1%
-
- Liver Disease Diagnosis and Treatment 12
-
- Metabolomics and Mass Spectrometry Studies 11
-
- Analytical Methods in Pharmaceuticals 11
- Co-authors
- Matthias SchwabMichel EichelbaumUlrich M. ZangerGerd MikusElke SchaeffelerKathrin KleinMartin F. FrommJoachim E. Fischer
- Journals
- Clinical Pharmacology & Therapeutics (17 papers)Drug Metabolism and Disposition (9 papers)Archives of Toxicology (6 papers)
- Partner nations
- GermanyEgyptUnited States
In The Last Decade
Ute Hofmann
179 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 147
- Pharmacology 1.6k
- Oncology 1.9k
- Anesthesiology and Pain Medicine 367
- Pediatrics, Perinatology and Child Health 983
- Biochemistry 295
Countries citing papers authored by Ute Hofmann
This map shows the geographic impact of Ute Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Hofmann more than expected).
Fields of papers citing papers by Ute Hofmann
This network shows the impact of papers produced by Ute Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Hofmann. The network helps show where Ute Hofmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ute Hofmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 16 | |
| 8 | 2022 | 9 | |
| 9 | 2020 | 49 | |
| 10 | 2020 | 14 | |
| 11 | 2017 | 24 | |
| 12 | 2013 | 52 | |
| 13 | 2010 | 19 | |
| 14 | 2005 | 16 | |
| 15 | 2002 | 106 | |
| 16 | 1999 | 25 | |
| 17 | 1999 | 20 | |
| 18 | 1996 | 5 | |
| 19 | 1990 | 11 | |
| 20 | Sequential formation of des a fibrin and des ab fibrin and binding of fibrinogen to des ab fibrin | 1981 | 9 |
About Ute Hofmann
Ute Hofmann is a scholar working on Pharmacology, Oncology and Pharmacology, having authored 183 papers that have together received 6.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (39 papers), Pharmacological Effects and Toxicity Studies (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Liver Disease Diagnosis and Treatment (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers), Drug-Induced Hepatotoxicity and Protection (11 papers) and Analytical Methods in Pharmaceuticals (11 papers). The work is most often cited by research in Pharmacology (1.6k citations), Oncology (1.9k citations) and Anesthesiology and Pain Medicine (367 citations). Ute Hofmann has collaborated with scholars based in Germany, Egypt and United States. Frequent co-authors include Matthias Schwab, Michel Eichelbaum, Ulrich M. Zanger, Gerd Mikus, Elke Schaeffeler, Kathrin Klein, Michel Eichelbaum, Martin F. Fromm, Joachim E. Fischer and Klaus Eckhardt. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition, Archives of Toxicology, British Journal of Clinical Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.